VA Announces Partnership to Aid Prostate Cancer Research
Washington, DC — The United States Department of Veterans Affairs (VA) has announced an important and substantial partnership with the Prostate Cancer Foundation (PCF) in order to prevent, screen and promote research to speed the development of treatments and cures for prostate cancer among Veterans.
The announcement of the partnership was made at LaunchPad, a recent VA summit aimed at finding clinical solutions to advance screening, diagnostics and care coordination for cancer and to promote the implementation of best practices across the VA healthcare system.
As part of the summit, the PCF announced a $50 million precision oncology initiative to expand prostate cancer clinical research among Veterans to speed the development of new treatment options and cures for prostate cancer patients. The agreement is the first between the PCF and VA, and comes at a time when an estimated 12,000 Veterans each year are diagnosed with prostate cancer – the most frequently diagnosed cancer among Veterans.
“Fighting and treating cancer among our Veterans is a team effort, which is why this LaunchPad event and this partnership are so important,” said VA Secretary Robert A. McDonald. “To effectively serve our Veterans and to keep VA on the cutting edge of medical research, we need government, corporate, and non-profit organizations working together. We are truly grateful to the Prostate Cancer Foundation for this important show of support. Our work together will save Veterans’ lives.” Continue>
Page | 1 2
Posted in: Smart Moves | July 14, 2014
Posted in: Smart Moves | October 25, 2016
Posted in: Smart Moves | February 18, 2014